title: [And spironolactone in the treatment of heart failure?].
authors.forename: F
authors.initials: F
authors.lastname: Sastre García
authors.forename: C
authors.initials: C
authors.lastname: García Bernabé
authors.forename: C
authors.initials: C
authors.lastname: López Reinoso
authors.forename: L
authors.initials: L
authors.lastname: Arribas Mir
mesh_terms: D002986:Clinical Trials as Topic; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone